Annual Nationwide Infection Trends for Revision Total Knee Arthroplasty
- PMID: 31491795
- DOI: 10.1055/s-0039-1696690
Annual Nationwide Infection Trends for Revision Total Knee Arthroplasty
Abstract
Several recent intraoperative and wound management techniques have been developed and implemented in the United States over the past decade; however, it is unclear what the effects of these newer modalities have on reducing surgical site infection (SSI) rates. Therefore, the purpose of this study was to track the annual rate and trends of (1) overall, (2) deep, and (3) superficial SSIs following revision total knee arthroplasty (TKA). The National Surgical Quality Improvement Program database was queried for all revision TKA cases performed between 2011 and 2016, which yielded 9,887 cases. Cases with superficial and/or deep SSIs were analyzed separately and then combined to evaluate overall SSI rates. After an overall 6-year correlation and trends analysis, univariate analysis was performed to compare the most recent year, 2016, with the preceding 5 years. Correlation coefficients and chi-square tests were used to determine correlation and statistical significance. No significant correlations between combined, deep, and/or superficial SSI rates and year were noted (p > 0.05). The lowest overall SSI incidence was in 2012 (1.16%), while the greatest incidence was in 2014 (1.76%). The deep SSI incidence over the 6 years was 0.67% (66 out of 9,887 cases). Deep SSI rate decreased by 10% in 2016 compared with 2011 (0.50 vs. 0.56%, p > 0.05). In this 6-year period, 94 cases out of 9,887 were complicated by a superficial SSI, an incidence of 0.95%. The lowest superficial SSI incidence occurred in 2015 (n = 17, 0.77%). Overall, the incidence of SSIs in revision TKA has remained fairly low with some annual variance, indicating room for improvement. These variations likely as revision surgeries can be more complex and have several associated confounding factors influencing outcomes, when compared with primary cases. Further research is needed to identify revision-specific strategies to reduce the risk of surgical site infections.
Thieme. All rights reserved.
Conflict of interest statement
C.A.H. reports 3M, American Association of Hip and Knee Surgeons, American Journal of Orthopedics, CD Diagnostics, Cempra, Cymedica, Journal of Hip Surgery, Journal of Knee Surgery, KCI, Mid-American Orthopaedic Association, Musculoskeletal Infection Society, Myoscience, National Quality Forum, OREF, Orthofix Inc., Pacira, Stryker, TenNor Therapeutics Limited, The Academy of Medicine of Cleveland & Northern Ohio, from Zimmer, outside the submitted work. S.K. reports Celanese, Ceramtec, Elsevier, Ferring Pharmaceuticals, Exponent, Invibio, Simplify Medical, Stelkast, Kyocera Medical, Wright Medical Technology, Lima Corporate, Stryker, Zimmer, outside the submitted work. M.A.M. reports Abbott, Cymedica, DJ Orthopaedics, Johnson & Johnson, Malinckrodt, Microport, Ongoing Care Support, Orthosensor, Pacira, Peerwell, Performance Dynamics, Sage, Stryker, TissueGene, outside the submitted work.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
